Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Double-blind, Sham-controlled Clinical Study Assessing the Safety and Efficacy of FibroNova for the Treatment of Fibromyalgia.

NCT06271746 is registered in ClinicalTrials.gov with Theranica as lead sponsor.

NCT NCT06271746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06271746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Double-blind, Sham-controlled Clinical Study Assessing the Safety and Efficacy of FibroNova for the Treatment of Fibromyalgia.
Lead sponsor
Theranica
Phase
Not applicable
Overall status
Unknown status
Start date
March 4, 2024
Completion date
June 1, 2025
Enrollment
170 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia